Abstract
Cdkn1a, which encodes p21, functions as a major route for p53-mediated cell-cycle arrest. However, the consequence of Cdkn1a gene dosage on tumor suppression has not been systematically investigated. Here, we employed BAC transgenesis to generate a Cdkn1aSUPER mouse, which harbors an additional Cdkn1a allele within its natural genomic context. We show that these mice display enhanced cell-cycle arrest and reduced apoptosis in response to genotoxic stress. Furthermore, using a chemically induced skin cancer model and an autochthonous Kras-driven lung adenocarcinoma model, we show that Cdkn1aSUPER mice display a cancer protection phenotype that is indistinguishable from that observed in Tp53SUPER animals. Moreover, we demonstrate that Tp53 and Cdkn1a cooperate in mediating cancer resistance, using a chemically induced fibrosarcoma model. Overall, our Cdkn1aSUPER allele enabled us to assess the contribution of Cdkn1a to Tp53-mediated tumor suppression. Torgovnick et al. create a mouse model, carrying a third copy of Cdkn1a (p21), which shows enhanced cell-cycle arrest capacity and protection against DNA damage-induced apoptosis. The Cdkn1aSUPER animals display delayed epithelial regeneration and a robust cancer resistance phenotype, highlighting the importance of p21 in p53-dependent tumor suppression.
| Original language | English |
|---|---|
| Journal | Cell Reports |
| Volume | 25 |
| Issue number | 4 |
| Pages (from-to) | 1027-1039.e6 |
| ISSN | 2211-1247 |
| DOIs | |
| Publication status | Published - 23.10.2018 |
Funding
We are indebted to M. Serrano (Institute for Research in Biomedicine; Barcelona) for providing cell lines derived from 3MC-induced sarcomas. M. van Vugt (Utrecht Medical Center) provided the GFP:53BP1 construct. We thank A. Florin and U. Rommerscheidt-Fuß from the Institute of Pathology, University Hospital Cologne, for their outstanding technical support. This work was supported by the Deutsche Forschungsgemeinschaft ( KFO-286/RP2 , RE 2246/2-1 , RE 2246/7-1 CECAD , SFB-829 to H.C.R., CECAD , SFB-829 , SFB-670 , KFO-286/RP1 , KFO-329 to B.S. and HE 6897/1-1 to G.S.H.-S.), the German federal state North Rhine Westphalia (NRW) as part of the EFRE initiative (grant LS-1-1-030a , H.C.R.), the Else Kröner-Fresenius Stiftung ( EKFS-2014-A06 , H.C.R.), the European Commission (ERC Starting grant 260383 and the FP7 Marie Curie Actions ITN CodeAge 316354 , ITN aDDRess 316390 , ITN MARRIAGE 316964 , and the Flag-Era-JTC2015 GRAPHENE to B.S.), the Deutsche Krebshilfe ( 111724 , H.C.R., 70112899 to B.S.), the Bundesministerium für Forschung und Bildung (Sybacol FKZ0315893 ) and the Koeln Fortune Program/Faculty of Medicine, University of Cologne ( 38/2010 to G.S.H.-S.). The results are in part based upon data generated by the TCGA Research Network: http://cancergenome.nih.gov/ .